Koninklijke Philips NV (AS:PHIA) — Market Cap & Net Worth
Market Cap & Net Worth: Koninklijke Philips NV (PHIA)
Koninklijke Philips NV (AS:PHIA) has a market capitalization of $24.32 Billion (€20.80 Billion) as of June 4, 2026. Listed on the AS stock exchange, this Netherlands-based company holds position #1078 globally and #10 in its home market, demonstrating a -5.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Koninklijke Philips NV's stock price €21.87 by its total outstanding shares 951289000 (951.29 Million). Review how much debt does Koninklijke Philips NV carry to assess the company's total debt and financial obligations.
Koninklijke Philips NV Market Cap History: 2015 to 2026
Koninklijke Philips NV's market capitalization history from 2015 to 2026. Data shows growth from $18.18 Billion to $24.32 Billion (3.20% CAGR).
Index Memberships
Koninklijke Philips NV is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
AEX Amsterdam Index
AEX
|
$1.08 Trillion | 2.25% | #10 of 25 |
|
STOXX Europe Large 200 EUR Price
LCXP
|
$7.02 Trillion | 0.35% | #74 of 182 |
|
STOXX Europe Large 200 Net Return
LCXR
|
$7.02 Trillion | 0.35% | #74 of 182 |
|
EuroNext 100
N100
|
$3.48 Trillion | 0.70% | #39 of 97 |
Weight: Koninklijke Philips NV's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Koninklijke Philips NV Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Koninklijke Philips NV's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.51x
Koninklijke Philips NV's market cap is 1.51 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $18.18 Billion | $24.24 Billion | $645.00 Million | 0.75x | 28.18x |
| 2016 | $23.18 Billion | $24.52 Billion | $1.45 Billion | 0.95x | 16.01x |
| 2017 | $25.83 Billion | $17.78 Billion | $1.66 Billion | 1.45x | 15.59x |
| 2018 | $25.90 Billion | $18.12 Billion | $1.09 Billion | 1.43x | 23.77x |
| 2019 | $37.30 Billion | $19.48 Billion | $1.17 Billion | 1.91x | 31.94x |
| 2020 | $39.17 Billion | $19.54 Billion | $1.19 Billion | 2.01x | 33.00x |
| 2021 | $29.84 Billion | $17.16 Billion | $3.32 Billion | 1.74x | 8.99x |
| 2022 | $13.23 Billion | $17.83 Billion | -$1.61 Billion | 0.74x | N/A |
| 2023 | $21.86 Billion | $18.17 Billion | -$466.00 Million | 1.20x | N/A |
| 2024 | $27.14 Billion | $18.02 Billion | -$702.00 Million | 1.51x | N/A |
Competitor Companies of PHIA by Market Capitalization
Companies near Koninklijke Philips NV in the global market cap rankings as of June 4, 2026.
Key companies related to Koninklijke Philips NV by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #154 globally with a market cap of $151.26 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #216 globally with a market cap of $112.89 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #259 globally with a market cap of $97.77 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #154 | Abbott Laboratories | NYSE:ABT | $151.26 Billion | $86.99 |
| #216 | Stryker Corporation | NYSE:SYK | $112.89 Billion | $295.00 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #259 | Medtronic PLC | NYSE:MDT | $97.77 Billion | $77.95 |
Koninklijke Philips NV Historical Marketcap From 2015 to 2026
Between 2015 and today, Koninklijke Philips NV's market cap moved from $18.18 Billion to $ 24.32 Billion, with a yearly change of 3.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €24.32 Billion | -5.90% |
| 2025 | €25.85 Billion | -4.75% |
| 2024 | €27.14 Billion | +24.16% |
| 2023 | €21.86 Billion | +65.17% |
| 2022 | €13.23 Billion | -55.66% |
| 2021 | €29.84 Billion | -23.81% |
| 2020 | €39.17 Billion | +5.01% |
| 2019 | €37.30 Billion | +44.00% |
| 2018 | €25.90 Billion | +0.29% |
| 2017 | €25.83 Billion | +11.43% |
| 2016 | €23.18 Billion | +27.52% |
| 2015 | €18.18 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 4th, 2026 the market cap of Koninklijke Philips NV was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.32 Billion USD |
| MoneyControl | $24.32 Billion USD |
| MarketWatch | $24.32 Billion USD |
| marketcap.company | $24.32 Billion USD |
| Reuters | $24.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Koninklijke Philips NV
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral… Read more